Immunicum is leveraging its unparalleled expertise in dendritic cell biology to develop novel, off-the-shelf, cell-based therapies for solid and blood-borne tumors.

Biotechnology

Immunicum

Immunicum's headquarters in Stockholm, Sweden

Erik Manting

Jeroen Rovers

Leopold Bertea

Alex Karlsson-Parra

Lotta Ferm

Lewis Lanier

Inge Marie Svane

Ada Kruisbeek

Sjoerd Van Der Burg

Tanja De Gruijl

Helén Tuvesson

Andrea Van Elsas

Sven Andreasson

Hans Preusting

Christine Lind

Dharminder Chahal

The Executive Management Team at Immunicum is responsible for strategic decision-making and overseeing the company's operations. They guide the development and commercialization of pioneering cell-based therapies for cancer, leveraging their expertise in dendritic cell biology to drive innovation, ensure regulatory compliance, and manage financial health.

Executive Management Team

The Scientific Advisory team at Immunicum provides strategic guidance and expert insights on dendritic cell biology and the development of novel cell-based therapies. They evaluate research findings, advise on clinical trial design, and ensure the scientific integrity and innovation of the company's therapeutic approaches for treating solid and blood-borne tumors.

Scientific Advisory

The Leadership Team at Immunicum is responsible for strategic direction and overall company governance, guiding the development of innovative cell-based therapies. By leveraging their diverse expertise in science, finance, and operations, the team collaborates to drive research initiatives, secure funding, and ensure alignment with the company’s mission to transform cancer treatment.

Leadership Team

Immunicum

Org chart

Board & advisors

Teams

Executive Management Team

Scientific Advisory

Leadership Team

Offices

Immunicum

Org chart

Board & advisors

Teams

Executive Management Team

Scientific Advisory

Leadership Team

Offices

Related companies